查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1862302

幹細胞療法：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 123 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球幹細胞治療市場預計在 2024 年達到 6.85 億美元，預計到 2031 年將達到 23.73 億美元，2025 年至 2031 年的複合年成長率為 19.7%。

幹細胞療法是指利用幹細胞治療或預防疾病。這些細胞可以分化成多種特化細胞，具有再生受損組織、調節免疫反應、恢復受損器官正常功能的潛力。其下游應用包括治療神經退化性疾病、心血管疾病、自體免疫疾病、整形外科損傷和某些癌症。

由於再生醫學需求不斷成長以及細胞研究技術的進步，全球幹細胞治療市場正蓬勃發展。各國政府和私營部門都在積極投資臨床試驗、研究基礎設施和商業化策略。帕金森氏症、第一型糖尿病和心臟衰竭等慢性退化性疾病發生率的上升，推動了幹細胞療法的應用。此外，患者和醫療專業人員對幹細胞療法潛力的認知不斷提高，也加速了其臨床應用。法律規範正在逐步完善，以適應幹細胞研究的獨特特點，但區域監管差距和倫理問題仍然是挑戰。學術機構、生技公司和醫院正在攜手合作，將實驗室研究成果轉化為臨床應用。持續創新可望將市場拓展至個人化醫療領域，特別是透過基因編輯技術和誘導性多功能幹細胞（iPSCs）的整合。

本報告旨在對全球幹細胞治療市場進行全面分析，重點關注總收入、企業市場占有率和主要企業的排名，以及按地區/國家、類型和應用對幹細胞治療進行分析。

本報告基於2020年至2031年的歷史數據和預測數據（以2024年為基準年），對幹細胞治療市場規模（按銷售收入計）進行了估算和預測。報告採用定量和定性分析相結合的方法，旨在幫助讀者制定業務/成長策略、評估競爭格局、分析自身在當前市場中的地位，並就幹細胞治療做出明智的商業決策。

市場區隔

公司

  • Medipost
  • Theracell Advanced Biotechnology
  • Nature Cell
  • Stempeutics
  • Regeneus
  • Bluebird bio, Inc
  • NIPRO
  • Kyowa Kirin
  • CorestemChemon Inc.
  • ANTEROGEN.CO., LTD.
  • Holostem
  • NuVasive
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Takeda（TiGenix）

按類型分類的細分市場

  • 異體幹細胞治療
  • 自體幹細胞療法

應用領域

  • 神經退化性疾病
  • 心血管疾病
  • 自體免疫疾病
  • 整形外科損傷
  • 癌症
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.

Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.

The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson's disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).

This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stem Cell Therapy by region & country, by Type, and by Application.

The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.

Market Segmentation

By Company

  • Medipost
  • Theracell Advanced Biotechnology
  • Nature Cell
  • Stempeutics
  • Regeneus
  • Bluebird bio, Inc
  • NIPRO
  • Kyowa Kirin
  • CorestemChemon Inc.
  • ANTEROGEN.CO., LTD.
  • Holostem
  • NuVasive
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Takeda (TiGenix)

Segment by Type

  • Allogeneic Stem Cell Therapies
  • Autologous Stem Cell Therapies

Segment by Application

  • Neurodegenerative Diseases
  • Cardiovascular Disorders
  • Autoimmune Conditions
  • Orthopedic Injuries
  • Cancer
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Stem Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Stem Cell Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Stem Cell Therapy Product Introduction
  • 1.2 Global Stem Cell Therapy Market Size Forecast (2020-2031)
  • 1.3 Stem Cell Therapy Market Trends & Drivers
    • 1.3.1 Stem Cell Therapy Industry Trends
    • 1.3.2 Stem Cell Therapy Market Drivers & Opportunity
    • 1.3.3 Stem Cell Therapy Market Challenges
    • 1.3.4 Stem Cell Therapy Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Stem Cell Therapy Players Revenue Ranking (2024)
  • 2.2 Global Stem Cell Therapy Revenue by Company (2020-2025)
  • 2.3 Key Companies Stem Cell Therapy Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Stem Cell Therapy Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Stem Cell Therapy
  • 2.6 Stem Cell Therapy Market Competitive Analysis
    • 2.6.1 Stem Cell Therapy Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Stem Cell Therapy Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Allogeneic Stem Cell Therapies
    • 3.1.2 Autologous Stem Cell Therapies
  • 3.2 Global Stem Cell Therapy Sales Value by Type
    • 3.2.1 Global Stem Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Stem Cell Therapy Sales Value, by Type (2020-2031)
    • 3.2.3 Global Stem Cell Therapy Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Neurodegenerative Diseases
    • 4.1.2 Cardiovascular Disorders
    • 4.1.3 Autoimmune Conditions
    • 4.1.4 Orthopedic Injuries
    • 4.1.5 Cancer
    • 4.1.6 Others
  • 4.2 Global Stem Cell Therapy Sales Value by Application
    • 4.2.1 Global Stem Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Stem Cell Therapy Sales Value, by Application (2020-2031)
    • 4.2.3 Global Stem Cell Therapy Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Stem Cell Therapy Sales Value by Region
    • 5.1.1 Global Stem Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Stem Cell Therapy Sales Value by Region (2020-2025)
    • 5.1.3 Global Stem Cell Therapy Sales Value by Region (2026-2031)
    • 5.1.4 Global Stem Cell Therapy Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Stem Cell Therapy Sales Value, 2020-2031
    • 5.2.2 North America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Stem Cell Therapy Sales Value, 2020-2031
    • 5.3.2 Europe Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Stem Cell Therapy Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Stem Cell Therapy Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Stem Cell Therapy Sales Value, 2020-2031
    • 5.5.2 South America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Stem Cell Therapy Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Stem Cell Therapy Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Stem Cell Therapy Sales Value, 2020-2031
    • 6.3.2 United States Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Stem Cell Therapy Sales Value, 2020-2031
    • 6.4.2 Europe Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Stem Cell Therapy Sales Value, 2020-2031
    • 6.5.2 China Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Stem Cell Therapy Sales Value, 2020-2031
    • 6.6.2 Japan Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Stem Cell Therapy Sales Value, 2020-2031
    • 6.7.2 South Korea Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Stem Cell Therapy Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Stem Cell Therapy Sales Value, 2020-2031
    • 6.9.2 India Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Stem Cell Therapy Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Medipost
    • 7.1.1 Medipost Profile
    • 7.1.2 Medipost Main Business
    • 7.1.3 Medipost Stem Cell Therapy Products, Services and Solutions
    • 7.1.4 Medipost Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Medipost Recent Developments
  • 7.2 Theracell Advanced Biotechnology
    • 7.2.1 Theracell Advanced Biotechnology Profile
    • 7.2.2 Theracell Advanced Biotechnology Main Business
    • 7.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Products, Services and Solutions
    • 7.2.4 Theracell Advanced Biotechnology Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Theracell Advanced Biotechnology Recent Developments
  • 7.3 Nature Cell
    • 7.3.1 Nature Cell Profile
    • 7.3.2 Nature Cell Main Business
    • 7.3.3 Nature Cell Stem Cell Therapy Products, Services and Solutions
    • 7.3.4 Nature Cell Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Nature Cell Recent Developments
  • 7.4 Stempeutics
    • 7.4.1 Stempeutics Profile
    • 7.4.2 Stempeutics Main Business
    • 7.4.3 Stempeutics Stem Cell Therapy Products, Services and Solutions
    • 7.4.4 Stempeutics Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Stempeutics Recent Developments
  • 7.5 Regeneus
    • 7.5.1 Regeneus Profile
    • 7.5.2 Regeneus Main Business
    • 7.5.3 Regeneus Stem Cell Therapy Products, Services and Solutions
    • 7.5.4 Regeneus Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Regeneus Recent Developments
  • 7.6 Bluebird bio, Inc
    • 7.6.1 Bluebird bio, Inc Profile
    • 7.6.2 Bluebird bio, Inc Main Business
    • 7.6.3 Bluebird bio, Inc Stem Cell Therapy Products, Services and Solutions
    • 7.6.4 Bluebird bio, Inc Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Bluebird bio, Inc Recent Developments
  • 7.7 NIPRO
    • 7.7.1 NIPRO Profile
    • 7.7.2 NIPRO Main Business
    • 7.7.3 NIPRO Stem Cell Therapy Products, Services and Solutions
    • 7.7.4 NIPRO Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.7.5 NIPRO Recent Developments
  • 7.8 Kyowa Kirin
    • 7.8.1 Kyowa Kirin Profile
    • 7.8.2 Kyowa Kirin Main Business
    • 7.8.3 Kyowa Kirin Stem Cell Therapy Products, Services and Solutions
    • 7.8.4 Kyowa Kirin Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Kyowa Kirin Recent Developments
  • 7.9 CorestemChemon Inc.
    • 7.9.1 CorestemChemon Inc. Profile
    • 7.9.2 CorestemChemon Inc. Main Business
    • 7.9.3 CorestemChemon Inc. Stem Cell Therapy Products, Services and Solutions
    • 7.9.4 CorestemChemon Inc. Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.9.5 CorestemChemon Inc. Recent Developments
  • 7.10 ANTEROGEN.CO., LTD.
    • 7.10.1 ANTEROGEN.CO., LTD. Profile
    • 7.10.2 ANTEROGEN.CO., LTD. Main Business
    • 7.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services and Solutions
    • 7.10.4 ANTEROGEN.CO., LTD. Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.10.5 ANTEROGEN.CO., LTD. Recent Developments
  • 7.11 Holostem
    • 7.11.1 Holostem Profile
    • 7.11.2 Holostem Main Business
    • 7.11.3 Holostem Stem Cell Therapy Products, Services and Solutions
    • 7.11.4 Holostem Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Holostem Recent Developments
  • 7.12 NuVasive
    • 7.12.1 NuVasive Profile
    • 7.12.2 NuVasive Main Business
    • 7.12.3 NuVasive Stem Cell Therapy Products, Services and Solutions
    • 7.12.4 NuVasive Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.12.5 NuVasive Recent Developments
  • 7.13 JCR Pharmaceutical
    • 7.13.1 JCR Pharmaceutical Profile
    • 7.13.2 JCR Pharmaceutical Main Business
    • 7.13.3 JCR Pharmaceutical Stem Cell Therapy Products, Services and Solutions
    • 7.13.4 JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.13.5 JCR Pharmaceutical Recent Developments
  • 7.14 Pharmicell
    • 7.14.1 Pharmicell Profile
    • 7.14.2 Pharmicell Main Business
    • 7.14.3 Pharmicell Stem Cell Therapy Products, Services and Solutions
    • 7.14.4 Pharmicell Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Pharmicell Recent Developments
  • 7.15 Medi-post
    • 7.15.1 Medi-post Profile
    • 7.15.2 Medi-post Main Business
    • 7.15.3 Medi-post Stem Cell Therapy Products, Services and Solutions
    • 7.15.4 Medi-post Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Medi-post Recent Developments
  • 7.16 Anterogen
    • 7.16.1 Anterogen Profile
    • 7.16.2 Anterogen Main Business
    • 7.16.3 Anterogen Stem Cell Therapy Products, Services and Solutions
    • 7.16.4 Anterogen Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Anterogen Recent Developments
  • 7.17 Takeda (TiGenix)
    • 7.17.1 Takeda (TiGenix) Profile
    • 7.17.2 Takeda (TiGenix) Main Business
    • 7.17.3 Takeda (TiGenix) Stem Cell Therapy Products, Services and Solutions
    • 7.17.4 Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Takeda (TiGenix) Recent Developments

8 Industry Chain Analysis

  • 8.1 Stem Cell Therapy Industrial Chain
  • 8.2 Stem Cell Therapy Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Stem Cell Therapy Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Stem Cell Therapy Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Stem Cell Therapy Market Trends
  • Table 2. Stem Cell Therapy Market Drivers & Opportunity
  • Table 3. Stem Cell Therapy Market Challenges
  • Table 4. Stem Cell Therapy Market Restraints
  • Table 5. Global Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Stem Cell Therapy Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Stem Cell Therapy Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Stem Cell Therapy Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Stem Cell Therapy
  • Table 10. Global Stem Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Stem Cell Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Stem Cell Therapy Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Stem Cell Therapy Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Stem Cell Therapy Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Stem Cell Therapy Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Stem Cell Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Stem Cell Therapy Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Stem Cell Therapy Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Stem Cell Therapy Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Stem Cell Therapy Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Stem Cell Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Stem Cell Therapy Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Stem Cell Therapy Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Stem Cell Therapy Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Stem Cell Therapy Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Stem Cell Therapy Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Stem Cell Therapy Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Medipost Basic Information List
  • Table 32. Medipost Description and Business Overview
  • Table 33. Medipost Stem Cell Therapy Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Stem Cell Therapy Business of Medipost (2020-2025)
  • Table 35. Medipost Recent Developments
  • Table 36. Theracell Advanced Biotechnology Basic Information List
  • Table 37. Theracell Advanced Biotechnology Description and Business Overview
  • Table 38. Theracell Advanced Biotechnology Stem Cell Therapy Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Stem Cell Therapy Business of Theracell Advanced Biotechnology (2020-2025)
  • Table 40. Theracell Advanced Biotechnology Recent Developments
  • Table 41. Nature Cell Basic Information List
  • Table 42. Nature Cell Description and Business Overview
  • Table 43. Nature Cell Stem Cell Therapy Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Stem Cell Therapy Business of Nature Cell (2020-2025)
  • Table 45. Nature Cell Recent Developments
  • Table 46. Stempeutics Basic Information List
  • Table 47. Stempeutics Description and Business Overview
  • Table 48. Stempeutics Stem Cell Therapy Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Stem Cell Therapy Business of Stempeutics (2020-2025)
  • Table 50. Stempeutics Recent Developments
  • Table 51. Regeneus Basic Information List
  • Table 52. Regeneus Description and Business Overview
  • Table 53. Regeneus Stem Cell Therapy Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Stem Cell Therapy Business of Regeneus (2020-2025)
  • Table 55. Regeneus Recent Developments
  • Table 56. Bluebird bio, Inc Basic Information List
  • Table 57. Bluebird bio, Inc Description and Business Overview
  • Table 58. Bluebird bio, Inc Stem Cell Therapy Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Stem Cell Therapy Business of Bluebird bio, Inc (2020-2025)
  • Table 60. Bluebird bio, Inc Recent Developments
  • Table 61. NIPRO Basic Information List
  • Table 62. NIPRO Description and Business Overview
  • Table 63. NIPRO Stem Cell Therapy Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Stem Cell Therapy Business of NIPRO (2020-2025)
  • Table 65. NIPRO Recent Developments
  • Table 66. Kyowa Kirin Basic Information List
  • Table 67. Kyowa Kirin Description and Business Overview
  • Table 68. Kyowa Kirin Stem Cell Therapy Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Stem Cell Therapy Business of Kyowa Kirin (2020-2025)
  • Table 70. Kyowa Kirin Recent Developments
  • Table 71. CorestemChemon Inc. Basic Information List
  • Table 72. CorestemChemon Inc. Description and Business Overview
  • Table 73. CorestemChemon Inc. Stem Cell Therapy Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Stem Cell Therapy Business of CorestemChemon Inc. (2020-2025)
  • Table 75. CorestemChemon Inc. Recent Developments
  • Table 76. ANTEROGEN.CO., LTD. Basic Information List
  • Table 77. ANTEROGEN.CO., LTD. Description and Business Overview
  • Table 78. ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Stem Cell Therapy Business of ANTEROGEN.CO., LTD. (2020-2025)
  • Table 80. ANTEROGEN.CO., LTD. Recent Developments
  • Table 81. Holostem Basic Information List
  • Table 82. Holostem Description and Business Overview
  • Table 83. Holostem Stem Cell Therapy Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Stem Cell Therapy Business of Holostem (2020-2025)
  • Table 85. Holostem Recent Developments
  • Table 86. NuVasive Basic Information List
  • Table 87. NuVasive Description and Business Overview
  • Table 88. NuVasive Stem Cell Therapy Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Stem Cell Therapy Business of NuVasive (2020-2025)
  • Table 90. NuVasive Recent Developments
  • Table 91. JCR Pharmaceutical Basic Information List
  • Table 92. JCR Pharmaceutical Description and Business Overview
  • Table 93. JCR Pharmaceutical Stem Cell Therapy Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Stem Cell Therapy Business of JCR Pharmaceutical (2020-2025)
  • Table 95. JCR Pharmaceutical Recent Developments
  • Table 96. Pharmicell Basic Information List
  • Table 97. Pharmicell Description and Business Overview
  • Table 98. Pharmicell Stem Cell Therapy Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Stem Cell Therapy Business of Pharmicell (2020-2025)
  • Table 100. Pharmicell Recent Developments
  • Table 101. Medi-post Basic Information List
  • Table 102. Medi-post Description and Business Overview
  • Table 103. Medi-post Stem Cell Therapy Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Stem Cell Therapy Business of Medi-post (2020-2025)
  • Table 105. Medi-post Recent Developments
  • Table 106. Anterogen Basic Information List
  • Table 107. Anterogen Description and Business Overview
  • Table 108. Anterogen Stem Cell Therapy Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Stem Cell Therapy Business of Anterogen (2020-2025)
  • Table 110. Anterogen Recent Developments
  • Table 111. Takeda (TiGenix) Basic Information List
  • Table 112. Takeda (TiGenix) Description and Business Overview
  • Table 113. Takeda (TiGenix) Stem Cell Therapy Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Stem Cell Therapy Business of Takeda (TiGenix) (2020-2025)
  • Table 115. Takeda (TiGenix) Recent Developments
  • Table 116. Key Raw Materials Lists
  • Table 117. Raw Materials Key Suppliers Lists
  • Table 118. Stem Cell Therapy Downstream Customers
  • Table 119. Stem Cell Therapy Distributors List
  • Table 120. Research Programs/Design for This Report
  • Table 121. Key Data Information from Secondary Sources
  • Table 122. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Stem Cell Therapy Product Picture
  • Figure 2. Global Stem Cell Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Stem Cell Therapy Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Stem Cell Therapy Report Years Considered
  • Figure 5. Global Stem Cell Therapy Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Stem Cell Therapy Revenue in 2024
  • Figure 7. Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Allogeneic Stem Cell Therapies Picture
  • Figure 9. Autologous Stem Cell Therapies Picture
  • Figure 10. Global Stem Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Stem Cell Therapy Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Neurodegenerative Diseases
  • Figure 13. Product Picture of Cardiovascular Disorders
  • Figure 14. Product Picture of Autoimmune Conditions
  • Figure 15. Product Picture of Orthopedic Injuries
  • Figure 16. Product Picture of Cancer
  • Figure 17. Product Picture of Others
  • Figure 18. Global Stem Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Stem Cell Therapy Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Stem Cell Therapy Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Stem Cell Therapy Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Stem Cell Therapy Sales Value (%), (2020-2031)
  • Figure 31. United States Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Stem Cell Therapy Industrial Chain
  • Figure 53. Stem Cell Therapy Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed